← FDA Drug Approvals (Drugs@FDA)

EPIRUBICIN HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS TOTOWA · Approved 2008-09-18

Drug application

FDA Application #
ANDA065445
Application type
Abbreviated New Drug Application (Generic)
Brand name
EPIRUBICIN HYDROCHLORIDE
Generic name
Epirubicin Hydrochloride
Active ingredients
EPIRUBICIN HYDROCHLORIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Discontinued
Sponsor
ACTAVIS TOTOWA
First approval
2008-09-18

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown